Limited-Time October Offer: Try 7 Days for Free

Novo Nordisk (NVO) Stock Price

$55.49 0%

Sign up
to add to portfolio

AI Score

  • Alternative

    6
  • Fundamental

    8
  • Technical

    3

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Novo Nordisk, AI stock picks, stock alerts and much more.

Sign up

NVO AI Stock Analysis

Financial Performance

Novo Nordisk has shown strong financial performance in the last quarter with revenue up by 20.2% from the previous quarter and up by 31.1% year over year to $85.7B. The gross profit also increased significantly, up by 21.1% from the previous quarter and up by 31.1% year over year to $72.7B, indicating a healthy margin expansion for the company.

The operating income was at $36.7B, showing an increase of 8.3% from the previous quarter and a rise of 13.3% YoY, which suggests efficient operations management within the company.

The EBITDA ratio stood at a decent level of .47 implying that Novo Nordisk is generating satisfactory earnings before interest, tax, depreciation and amortization.

Stock Price

The stock price has been on a downward trend as it's currently trading at $47.28, down -29.7% in the last month and -62.5% YoY which might raise concerns among investors regarding its short-term performance.

However, technical indicators such as RSI value (22.75) suggest that the stock could be oversold and may rebound soon while its PE ratio stands at 12.95 which indicates reasonable valuation levels compared to its earnings per share (EPS) of $3.65.

Alternative Data Signals

Negative trends are observed when looking at alternative data signals such as website traffic which is down by -6..3%, MoM and -20.% YoY along with job postings that have decreased by -13.% MoM and -18.% YoY.

However, the company shows strong social media presence with increasing followers across Twitter, Instagram and Facebook. The employee business outlook remains quite positive at 81%, despite a slight decrease YoY.

Conclusion

In conclusion, despite the short-term decline in stock price and some negative trends in alternative data signals like website traffic and job postings, Novo Nordisk's strong financial performance, reasonable valuation levels and positive business outlook suggest that it has potential for recovery making its stock neutral from an investment perspective.

Note: This AI Stock Analysis is based on data as of August 05. Our members can refresh and get access to an up-to-date AI stock analysis.

Sign up

Novo Nordisk (NVO) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Novo Nordisk (NVO), currently trading at $55.49, will... Sign up to access price prediction.

About NVO

LSE
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide.

  • Symbol

    NVO

  • Market

    NYSE

  • Industry

    Biotechnology

  • Market Cap

    246.6B

Similar Stocks

ZYME Zymeworks
ZYME
$17.08
0.9%
6
DNA Ginkgo Bioworks Holdings
DNA
$14.58
10.2%
4
RCUS Arcus Biosciences
RCUS
$13.6
2.1%
5

NVO Alternative Data

Web Traffic

Novo Nordisk receives an estimated 736226 monthly visitors to novonordisk.com.

  • Web Traffic

    736226

  • Change from Previous Month

    3.8%

  • 3 Month Change

    21.8%

  • YoY Change

    21.8%

Twitter Followers

Novo Nordisk has 52,738 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.8% over the last month.

  • Twitter Followers

    52738

  • Daily Change

    0%

  • 1 Month Change

    0.8%

  • 3 Month Change

    2.9%

  • YoY Change

    2.9%

Facebook Engagement

Novo Nordisk has engaged 36,260 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    36260

  • Daily Change

    6.8%

  • 1 Month Change

    39.3%

  • 3 Month Change

    14.2%

  • YoY Change

    14.2%

Instagram Followers

Novo Nordisk has 153,831 Instagram Followers on its main Instagram account, up by 2.2% over the last month.

  • Instagram Followers

    153831

  • Daily Change

    0.1%

  • 1 Month Change

    2.2%

  • 3 Month Change

    4.9%

  • YoY Change

    4.9%

Youtube Subscribers

Novo Nordisk has 42,900 subscribers on its main Youtube channel, up by 2.1% over the last month.

  • Youtube Subscribers

    42900

  • Daily Change

    0.2%

  • 1 Month Change

    2.1%

  • 3 Month Change

    3.9%

  • YoY Change

    3.9%

Job Postings

Novo Nordisk has an estimated 69 open job postings, which is down -73.4% over the last month.

  • Job Postings

    69

  • Daily Change

    1.5%

  • 1 Month Change

    73.4%

  • 3 Month Change

    91.2%

  • YoY Change

    91.2%

LinkedIn Employees

According to LinkedIn, Novo Nordisk has 67,462 employees, up by 0.8% over the last month.

  • LinkedIn Employees

    67462

  • Daily Change

    0%

  • 1 Month Change

    0.8%

  • 3 Month Change

    1.9%

  • YoY Change

    1.9%

Reddit Mentions

Novo Nordisk has been mentioned an estimated 37 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    37

  • Daily Change

    26%

  • 1 Month Change

    516.7%

  • 3 Month Change

    362.5%

Reddit Sentiment

The sentiment Score for Novo Nordisk is 55 out of 100, which represents a neutral sentiment.

  • Reddit Sentiment

    54.85

  • Daily Change

    10.4%

  • 1 Month Change

    24.2%

  • 3 Month Change

    15.9%

Business Outlook

According to employee reviews, the business outlook among employees at Novo Nordisk is 77 out of 100 (bullish).

  • Business Outlook

    77

  • Change from Previous Month

    3.8%

  • 3 Month Change

    4.9%

  • YoY Change

    4.9%

LinkedIn Followers

2,310,547 are following Novo Nordisk on LinkedIn.

  • LinkedIn Followers

    2310547

  • 1 Month Change

    0%

  • 3 Month Change

    0%

News Mentions

Novo Nordisk was mentioned 14 times in the news yesterday.

  • News Mentions

    14

  • Daily Change

    12.5%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

NVO Financials

NVO Key Metrics
  • Total Revenue

    DKK85.7B

  • Net Income

    DKK28.2B

  • Earnings per Share

    DKK6.34

  • Free cash flow

    -DKK4.3B

  • EBITDA

    DKK40.1B

  • EBITDA Ratio

    0.468494

  • Total Assets

    DKK465.8B

NVO 2-year Revenue & Income
NVO 2-year Free Cash Flow

NVO Technicals

NVO SMA
NVO RSI

FAQ

What's the current price of Novo Nordisk (NVO) Stock?
The price of an Novo Nordisk (NVO) share is $55.49.

What's the market cap of Novo Nordisk?
The current market cap of Novo Nordisk is 246.6B.

What are some stocks similar to Novo Nordisk (NVO) that investors often compare it to?
Novo Nordisk (NVO) is often compared to similar stocks such as Zymeworks, Ginkgo Bioworks Holdings and Arcus Biosciences.

What is the forecast for Novo Nordisk's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Novo Nordisk's stock price to be around $56.74 in 2026. Starting from the current price of $55.49, this represents a 2.3% change in price, indicating a neutral outlook for the stock.

How to buy Novo Nordisk (NVO) Stock?
Novo Nordisk stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Novo Nordisk shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.